A Case of Violent Suicide Attempt in a Context of Myxedema Psychosis following Radioiodine Treatment in a Patient with Graves' Disease.


Journal

Case reports in psychiatry
ISSN: 2090-682X
Titre abrégé: Case Rep Psychiatry
Pays: United States
ID NLM: 101583308

Informations de publication

Date de publication:
2019
Historique:
received: 28 09 2018
revised: 30 11 2018
accepted: 14 12 2018
entrez: 8 2 2019
pubmed: 8 2 2019
medline: 8 2 2019
Statut: epublish

Résumé

Hypothyroidism has been associated with mood disorders but some cases of acute psychosis have also been reported. However, less attention has been paid to suicidal behavior in these patients. We report a case of suicide attempt by self-stabbing in a 43-year-old woman without past psychiatric history, four months after radioiodine therapy for Graves' disease. On clinical examination remarkable signs of myxedema were found and blood investigations showed hypothyroidism with an extremely high thyroid stimulating hormone (TSH) level (152 mUI/L; reference range 0.20-5.10). The patient presented delirium symptoms at the time of self-stabbing, which was associated with persecutory delusions and auditory harm command hallucinations. A rapid physical and psychiatric improvement was observed after the initiation of an oral thyroid replacement therapy without relapse after early discontinuation of the antipsychotic treatment. The most distinctive feature of our case is that the violent suicide attempt could be attributed to the myxedema psychosis. Suicide may result from several factors, including psychosocial stressors, psychiatric symptoms, and hormonal disturbance. This unique presentation should remind clinicians to systematically consider ordering additional tests in patients with atypical psychiatric presentation, even when serious behavioral disorders (such as violent suicide attempts) are present and may result in premature transfer to psychiatric units.

Identifiants

pubmed: 30729057
doi: 10.1155/2019/4972760
pmc: PMC6343151
doi:

Types de publication

Case Reports

Langues

eng

Pagination

4972760

Références

Mol Psychiatry. 2002;7(2):140-56
pubmed: 11840307
Prim Care Companion J Clin Psychiatry. 2003 Dec;5(6):260-266
pubmed: 15213796
Br Med J. 1949 Sep 10;2(4627):555-62
pubmed: 18148089
Gen Hosp Psychiatry. 2008 Jul-Aug;30(4):356-9
pubmed: 18585540
Am J Psychiatry. 2009 Sep;166(9):1067-8
pubmed: 19723801
Psychoneuroendocrinology. 2010 Aug;35(7):1045-54
pubmed: 20129737
Psychiatry Res. 2012 Dec 30;200(2-3):389-94
pubmed: 22748186
BMJ Case Rep. 2010 Sep 17;2010:null
pubmed: 22778250
JRSM Short Rep. 2013 Apr;4(4):26
pubmed: 23560226
Am J Psychiatry. 2014 Dec 1;171(12):1259-77
pubmed: 25263730
Endocrinol Diabetes Metab Case Rep. 2015;2015:150087
pubmed: 26525086
J Psychiatr Pract. 2015 Nov;21(6):445-8
pubmed: 26554328
Psychoneuroendocrinology. 2017 Nov;85:100-109
pubmed: 28843902

Auteurs

Louise Todorov (L)

AP-HP, Hôpitaux Universitaires Paris Ouest, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Paris, France.

Amel Ait Boudaoud (A)

AP-HP, Hôpitaux Universitaires Paris Ouest, Service de Nutrition, UF Endocrinologie-Diabétologie, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France.

Rachel Pascal de Raykeer (R)

AP-HP, Hôpitaux Universitaires Paris Ouest, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Paris, France.

Alina Radu (A)

AP-HP, Hôpitaux Universitaires Paris Ouest, Service de Nutrition, UF Endocrinologie-Diabétologie, Paris, France.

Khadija Lahlou-Laforêt (K)

AP-HP, Hôpitaux Universitaires Paris Ouest, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Paris, France.

Frédéric Limosin (F)

AP-HP, Hôpitaux Universitaires Paris Ouest, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France.
Inserm, U894, Centre Psychiatrie et Neurosciences, Paris, France.

Cédric Lemogne (C)

AP-HP, Hôpitaux Universitaires Paris Ouest, Service de Psychiatrie de l'Adulte et du Sujet Âgé, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France.
Inserm, U894, Centre Psychiatrie et Neurosciences, Paris, France.

Sébastien Czernichow (S)

AP-HP, Hôpitaux Universitaires Paris Ouest, Service de Nutrition, UF Endocrinologie-Diabétologie, Paris, France.
Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, Paris, France.

Classifications MeSH